
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Cytokines in the Treatment of Cancer
Kevin C. Conlon, Miloš D. Miljković, Thomas A. Waldmann
Journal of Interferon & Cytokine Research (2018) Vol. 39, Iss. 1, pp. 6-21
Open Access | Times Cited: 413
Kevin C. Conlon, Miloš D. Miljković, Thomas A. Waldmann
Journal of Interferon & Cytokine Research (2018) Vol. 39, Iss. 1, pp. 6-21
Open Access | Times Cited: 413
Showing 1-25 of 413 citing articles:
Inflammation and tumor progression: signaling pathways and targeted intervention
Huakan Zhao, Lei Wu, Guifang Yan, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 1611
Huakan Zhao, Lei Wu, Guifang Yan, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 1611
The Crosstalk Between Tumor Cells and the Immune Microenvironment in Breast Cancer: Implications for Immunotherapy
Vincenzo Salemme, Giorgia Centonze, Federica Cavallo, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 184
Vincenzo Salemme, Giorgia Centonze, Federica Cavallo, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 184
Bispecific T-cell engagers: Towards understanding variables influencing the in vitro potency and tumor selectivity and their modulation to enhance their efficacy and safety
Diego Ellerman
Methods (2018) Vol. 154, pp. 102-117
Open Access | Times Cited: 171
Diego Ellerman
Methods (2018) Vol. 154, pp. 102-117
Open Access | Times Cited: 171
If we build it they will come: targeting the immune response to breast cancer
Margaret E. Gatti‐Mays, Justin M. Balko, Sofia R. Gameiro, et al.
npj Breast Cancer (2019) Vol. 5, Iss. 1
Open Access | Times Cited: 170
Margaret E. Gatti‐Mays, Justin M. Balko, Sofia R. Gameiro, et al.
npj Breast Cancer (2019) Vol. 5, Iss. 1
Open Access | Times Cited: 170
Human immunology and immunotherapy: main achievements and challenges
Jezabel Varadé, Susana Magadán, África González‐Fernández
Cellular and Molecular Immunology (2020) Vol. 18, Iss. 4, pp. 805-828
Open Access | Times Cited: 156
Jezabel Varadé, Susana Magadán, África González‐Fernández
Cellular and Molecular Immunology (2020) Vol. 18, Iss. 4, pp. 805-828
Open Access | Times Cited: 156
Managing Metastatic Melanoma in 2022: A Clinical Review
Benjamin Switzer, Igor Puzanov, Joseph J. Skitzki, et al.
JCO Oncology Practice (2022) Vol. 18, Iss. 5, pp. 335-351
Open Access | Times Cited: 147
Benjamin Switzer, Igor Puzanov, Joseph J. Skitzki, et al.
JCO Oncology Practice (2022) Vol. 18, Iss. 5, pp. 335-351
Open Access | Times Cited: 147
Tumor immune contexture is a determinant of anti-CD19 CAR T cell efficacy in large B cell lymphoma
Nathalie Scholler, Régis Perbost, Frederick L. Locke, et al.
Nature Medicine (2022) Vol. 28, Iss. 9, pp. 1872-1882
Open Access | Times Cited: 132
Nathalie Scholler, Régis Perbost, Frederick L. Locke, et al.
Nature Medicine (2022) Vol. 28, Iss. 9, pp. 1872-1882
Open Access | Times Cited: 132
Nanomaterials in tumor immunotherapy: new strategies and challenges
Xudong Zhu, Shenglong Li
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 110
Xudong Zhu, Shenglong Li
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 110
Designing Cancer Immunotherapies That Engage T Cells and NK Cells
Oleksandr Kyrysyuk, Kai W. Wucherpfennig
Annual Review of Immunology (2022) Vol. 41, Iss. 1, pp. 17-38
Open Access | Times Cited: 107
Oleksandr Kyrysyuk, Kai W. Wucherpfennig
Annual Review of Immunology (2022) Vol. 41, Iss. 1, pp. 17-38
Open Access | Times Cited: 107
Oncolytic virus therapy in cancer: A current review
Jonathan Santos Apolonio, Vinícius Lima de Souza Gonçalves, Maria Luísa Cordeiro Santos, et al.
World Journal of Virology (2021) Vol. 10, Iss. 5, pp. 229-255
Open Access | Times Cited: 105
Jonathan Santos Apolonio, Vinícius Lima de Souza Gonçalves, Maria Luísa Cordeiro Santos, et al.
World Journal of Virology (2021) Vol. 10, Iss. 5, pp. 229-255
Open Access | Times Cited: 105
Current and emerging therapeutic approaches for colorectal cancer: A comprehensive review
Anil Kumar, Vipasha Gautam, Arushi Sandhu, et al.
World Journal of Gastrointestinal Surgery (2023) Vol. 15, Iss. 4, pp. 495-519
Open Access | Times Cited: 93
Anil Kumar, Vipasha Gautam, Arushi Sandhu, et al.
World Journal of Gastrointestinal Surgery (2023) Vol. 15, Iss. 4, pp. 495-519
Open Access | Times Cited: 93
The expanding role for small molecules in immuno-oncology
Rienk Offringa, Lisa Kötzner, Bayard R. Huck, et al.
Nature Reviews Drug Discovery (2022) Vol. 21, Iss. 11, pp. 821-840
Closed Access | Times Cited: 86
Rienk Offringa, Lisa Kötzner, Bayard R. Huck, et al.
Nature Reviews Drug Discovery (2022) Vol. 21, Iss. 11, pp. 821-840
Closed Access | Times Cited: 86
Targeting cytokine and chemokine signaling pathways for cancer therapy
Ming Yi, Tianye Li, Mengke Niu, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 60
Ming Yi, Tianye Li, Mengke Niu, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 60
Recent Advances in Molecular Mechanisms of Cancer Immunotherapy
Mateusz Kciuk, Esam Bashir Yahya, Montaha Mohamed Ibrahim Mohamed, et al.
Cancers (2023) Vol. 15, Iss. 10, pp. 2721-2721
Open Access | Times Cited: 53
Mateusz Kciuk, Esam Bashir Yahya, Montaha Mohamed Ibrahim Mohamed, et al.
Cancers (2023) Vol. 15, Iss. 10, pp. 2721-2721
Open Access | Times Cited: 53
Uncovering the complex role of interferon-gamma in suppressing type 2 immunity to cancer
Asif Ahmad Bhat, Ahsas Goyal, Riya Thapa, et al.
Cytokine (2023) Vol. 171, pp. 156376-156376
Closed Access | Times Cited: 49
Asif Ahmad Bhat, Ahsas Goyal, Riya Thapa, et al.
Cytokine (2023) Vol. 171, pp. 156376-156376
Closed Access | Times Cited: 49
Normalization of the tumor microenvironment by harnessing vascular and immune modulation to achieve enhanced cancer therapy
Yechan Choi, Keehoon Jung
Experimental & Molecular Medicine (2023) Vol. 55, Iss. 11, pp. 2308-2319
Open Access | Times Cited: 42
Yechan Choi, Keehoon Jung
Experimental & Molecular Medicine (2023) Vol. 55, Iss. 11, pp. 2308-2319
Open Access | Times Cited: 42
The paradoxical role of cytokines and chemokines at the tumor microenvironment: a comprehensive review
Toufik Abdul‐Rahman, Shankhaneel Ghosh, Sarah M. Badar, et al.
European journal of medical research (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 31
Toufik Abdul‐Rahman, Shankhaneel Ghosh, Sarah M. Badar, et al.
European journal of medical research (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 31
Dietary factors and their influence on immunotherapy strategies in oncology: a comprehensive review
Aleksandra Golonko, Tomasz Pienkowski, Renata Świsłocka, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 4
Open Access | Times Cited: 19
Aleksandra Golonko, Tomasz Pienkowski, Renata Świsłocka, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 4
Open Access | Times Cited: 19
The Progress and Prospects of Immune Cell Therapy for the Treatment of Cancer
Jia Han, B. Zhang, Senyu Zheng, et al.
Cell Transplantation (2024) Vol. 33
Open Access | Times Cited: 17
Jia Han, B. Zhang, Senyu Zheng, et al.
Cell Transplantation (2024) Vol. 33
Open Access | Times Cited: 17
The JAK-STAT pathway: from structural biology to cytokine engineering
You Lv, Jianxun Qi, Jeffrey J. Babon, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 17
You Lv, Jianxun Qi, Jeffrey J. Babon, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 17
Soluble PD-1: Predictive, Prognostic, and Therapeutic Value for Cancer Immunotherapy
Muhammad Khan, Zhihong Zhao, Sumbal Arooj, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 131
Muhammad Khan, Zhihong Zhao, Sumbal Arooj, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 131
Tweak to Treat: Reprograming Bacteria for Cancer Treatment
Brendan Fu‐Long Sieow, K.S. Wun, Wei Peng Yong, et al.
Trends in cancer (2020) Vol. 7, Iss. 5, pp. 447-464
Open Access | Times Cited: 111
Brendan Fu‐Long Sieow, K.S. Wun, Wei Peng Yong, et al.
Trends in cancer (2020) Vol. 7, Iss. 5, pp. 447-464
Open Access | Times Cited: 111
Advances in Sweat Wearables: Sample Extraction, Real-Time Biosensing, and Flexible Platforms
Laicong Qiao, Mercy R. Benzigar, J. Anand Subramony, et al.
ACS Applied Materials & Interfaces (2020) Vol. 12, Iss. 30, pp. 34337-34361
Closed Access | Times Cited: 101
Laicong Qiao, Mercy R. Benzigar, J. Anand Subramony, et al.
ACS Applied Materials & Interfaces (2020) Vol. 12, Iss. 30, pp. 34337-34361
Closed Access | Times Cited: 101
Alginate derived functional oligosaccharides: Recent developments, barriers, and future outlooks
Ushasree Mrudulakumari Vasudevan, Ok Kyung Lee, Eun Yeol Lee
Carbohydrate Polymers (2021) Vol. 267, pp. 118158-118158
Closed Access | Times Cited: 98
Ushasree Mrudulakumari Vasudevan, Ok Kyung Lee, Eun Yeol Lee
Carbohydrate Polymers (2021) Vol. 267, pp. 118158-118158
Closed Access | Times Cited: 98
The Role of Cytokines in Predicting the Response and Adverse Events Related to Immune Checkpoint Inhibitors
Min Wang, Xiaoyang Zhai, Ji Li, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 95
Min Wang, Xiaoyang Zhai, Ji Li, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 95